Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
letter
. 1983 Oct 8;287(6398):1064–1065. doi: 10.1136/bmj.287.6398.1064-b

Prevention of coronary heart disease.

C R Kay
PMCID: PMC1549565  PMID: 6412948

Full text

PDF
1064

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives. Lancet. 1977 Mar 19;1(8012):624–624. [PubMed] [Google Scholar]
  2. Kay C. R. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):762–765. doi: 10.1016/s0002-9378(16)32485-1. [DOI] [PubMed] [Google Scholar]
  3. Khaw K. T., Peart W. S. Blood pressure and contraceptive use. Br Med J (Clin Res Ed) 1982 Aug 7;285(6339):403–407. doi: 10.1136/bmj.285.6339.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Meade T. W., Greenberg G., Thompson S. G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J. 1980 May 10;280(6224):1157–1161. doi: 10.1136/bmj.280.6224.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Slone D., Shapiro S., Kaufman D. W., Rosenberg L., Miettinen O. S., Stolley P. D. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med. 1981 Aug 20;305(8):420–424. doi: 10.1056/NEJM198108203050802. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES